Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22616137 | 0.93 | EPHX1 (0.34) | EPHX1 | |
| SCHEMBL43311 | 0.89 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL28036536 | 0.87 | EPHX1 (0.30) | EPHX1 | |
| SCHEMBL2450589 | 0.85 | — | — | |
| SCHEMBL21166294 | 0.80 | EPHX1 (0.31) | EPHX1 | |
| Acetic Acid SCHEMBL28142617 | 0.76 | GLA (0.40) | EPHX1 | |
| SCHEMBL1191684 | 0.76 | — | — | |
| SCHEMBL9868537 | 0.75 | — | — | |
| SCHEMBL9782936 | 0.75 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL863460 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 351 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1379577-B1 | CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES | SOLUTIA INC (US) | 2004-08-25 | — | — | EP | claimed |
| US-6737159-B2 | Controlling solar radiation in safety glass laminates | SOLUTIA, INC. | 2004-05-18 | — | — | US | claimed |
| EP-1379577-A1 | CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES | Solutia Inc. (US) | 2004-01-14 | — | — | EP | claimed |
| US-20020182422-A1 | Controlling solar radiation in safety glass laminates | SOLUTIA INC. | 2002-12-05 | — | — | US | claimed |
| WO-2002077081-A1 | CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES | SOLUTIA, INC. (US) | 2002-10-03 | — | — | WO | claimed |
| CN-115175967-B | Ionic liquids for stabilizing viscosity of silicate-based coatings | 巴斯夫欧洲公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-113330096-B | Use of substituted or unsubstituted polycyclic aromatic compounds for high resolution microscopy | 马克斯·普朗克索赔科学公司 | 2024-05-31 | — | — | CN | disclosed |
| US-11958796-B2 | Hydrophilic and particularly water soluble DBOV-derivatives | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2024-04-16 | — | — | US | disclosed |
| CN-112839922-B | Hydrophilic and in particular water-soluble DBOV derivatives | 马克斯·普朗克索赔科学公司 | 2024-04-02 | — | — | CN | disclosed |
| EP-3183250-B1 | PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | CLAP CO LTD (KR) | 2023-10-04 | — | — | EP | disclosed |
| US-20230303608-A1 | DITHIOLENE METAL COMPLEXES | BASF SCHWEIZ AG (CH) | 2023-09-28 | — | — | US | disclosed |
| EP-4182395-A1 | DITHIOLENE METAL COMPLEXES | BASF SE (DE) | 2023-05-24 | — | — | EP | disclosed |
| US-20040068114-A1 | Rylene derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2004-04-08 | — | — | US | disclosed |
| US-20040049030-A1 | Tert alkylphenoxy substituted polycyclic compounds | BASF SE (DE) | 2004-03-11 | — | — | US | disclosed |
| EP-1379577-A1 | CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES | Solutia Inc. (US) | 2004-01-14 | — | — | EP | disclosed |
| US-20020182422-A1 | Controlling solar radiation in safety glass laminates | SOLUTIA INC. | 2002-12-05 | — | — | US | disclosed |
| US-6486319-B1 | Thermochromic rylene dyes | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-26 | — | — | US | disclosed |
| WO-2002077081-A1 | CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES | SOLUTIA, INC. (US) | 2002-10-03 | — | — | WO | disclosed |
| EP-1206456-A1 | THERMOCHROMIC RYLENE DYES | BASF AKTIENGESELLSCHAFT (DE) | 2002-05-22 | — | — | EP | disclosed |
| WO-2001016109-A1 | THERMOCHROMIC RYLENE DYES | BASF AKTIENGESELLSCHAFT (DE) | 2001-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303608-A1 | DITHIOLENE METAL COMPLEXES | TST, C1S, F12 | EPHX1 3782/4885 |
| US-11958796-B2 | Hydrophilic and particularly water soluble DBOV-derivatives | NR1H4, HDGF, ABHD16A | EPHX1 398/4885 |
| US-20040049030-A1 | Tert alkylphenoxy substituted polycyclic compounds | NR3C1, NR1H4, NR5A1 | EPHX1 2270/4885 |
| US-20040068114-A1 | Rylene derivatives | RER1, MALT1, GHSR | EPHX1 3725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.